Study kidney tumor genetic change in young patients
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at a specific genetic change in kidney tumors in children, teens, and young adults up to age 30. It aims to understand how that change affects patients who are newly diagnosed or whose cancer has come back, and may guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 30 or younger (child, teen, or young adult)
- Have a kidney tumor that is new or has come back (primary or relapsed)
- Get care at a study center that participates in SIOP-RTSG
- Agree to take part in the study
- Have informed consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genetic features of kidney cancer by testing tumor samples. The goal is to find biomarkers—specific signs—that may help predict what kind of kidney cancer it is.
This study is a registry that collects information on how people with localized kidney tumors are treated (either active treatment or watchful waiting). It may help doctors better understand which approaches work best for different patients.
This study looks at the genetic (DNA) features of tumors in children, teens, and young adults with osteosarcoma, Ewing sarcoma, or synovial sarcoma. It may help researchers better understand these cancers by analyzing a fresh tumor sample and a blood sample.
This is a long-term study that watches children and young adults with chronic kidney disease to understand how the illness changes and to improve care. You may be asked to complete regular visits and questionnaires, and your kidney function will be tracked over time.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study follows people with kidney cancer who are scheduled for surgery to remove their tumor. It aims to learn more about the disease and how it behaves over time.
Hear when a new Kidney Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.